Bruderman Asset Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,404
Closed -$261K 75
2022
Q1
$261K Sell
2,404
-608
-20% -$62.7K 0.39% 59
2021
Q4
$390K Sell
3,012
-1,688
-36% -$207K 0.3% 67
2021
Q3
$569K Buy
4,700
+524
+13% +$63.8K 0.14% 79
2021
Q2
$471K Buy
4,176
+236
+6% +$24.8K 0.15% 54
2021
Q1
$376K Sell
3,940
-4
-0.1% -$365 0.1% 85
2020
Q4
$313K Buy
3,944
+608
+18% +$44K 0.09% 87
2020
Q3
$207K Buy
3,336
+120
+4% +$7.81K 0.07% 90
2020
Q2
$214K Buy
+3,216
New +$193K 0.07% 87
2019
Q2
Sell
-2,704
Closed -$134K 519
2019
Q1
$134K Buy
2,704
+220
+9% +$9.9K 0.03% 152
2018
Q4
$90K Sell
2,484
-340
-12% -$14.2K 0.02% 188
2018
Q3
$144K Sell
2,824
-232
-8% -$10.3K 0.03% 120
2018
Q2
$113K Buy
+3,056
New +$117K 0.03% 160

Other funds holding TECH

Bruderman Asset Management's TECH Position: Q2 2022 in Review

Bruderman Asset Management sold out of Bio-Techne (TECH) in Q2 2022, closing a stake of 2,404 shares — an estimated $261K sold.

Bruderman Asset Management first reported a position in TECH in Q2 2018 and held it in 12 quarters. The position peaked at $569K in Q3 2021. 549 funds tracked by Wall St. Rank hold TECH as of Q2 2022.

  • Bruderman Asset Management reported no remaining Bio-Techne position as of Q2 2022 after selling out during the quarter.
  • Bruderman Asset Management sold 2,404 Bio-Techne shares in Q2 2022, an estimated $261K.
  • Bruderman Asset Management first reported a position in Bio-Techne in Q2 2018 and held it in 12 quarters.
  • Bruderman Asset Management's Bio-Techne position peaked at $569K in Q3 2021.
  • 549 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2022.

Based on Bruderman Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.